|
[1]
|
The Unique Molecular and Cellular Microenvironment of Ovarian Cancer
Frontiers in Oncology,
2017
DOI:10.3389/fonc.2017.00024
|
|
|
|
|
[2]
|
Circulating Tumor Cells Expressing Markers of Tumor-Initiating Cells Predict Poor Survival and Cancer Recurrence in Patients with Pancreatic Ductal Adenocarcinoma
Clinical Cancer Research,
2017
DOI:10.1158/1078-0432.CCR-16-1467
|
|
|
|
|
[3]
|
Cancer stem cells in human gastrointestinal cancer
Cancer Science,
2016
DOI:10.1111/cas.13069
|
|
|
|
|
[4]
|
Cancer stem cells in human gastrointestinal cancer
Cancer Science,
2016
DOI:10.1111/cas.13069
|
|
|
|
|
[5]
|
A multi-stage process including transient polyploidization and EMT precedes the emergence of chemoresistent ovarian carcinoma cells with a dedifferentiated and pro-inflammatory secretory phenotype
Oncotarget,
2015
DOI:10.18632/oncotarget.5552
|
|
|
|
|
[6]
|
The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients
Cellular Oncology,
2013
DOI:10.1007/s13402-013-0142-8
|
|
|
|
|
[7]
|
Aiming to immune elimination of ovarian cancer stem cells
World Journal of Stem Cells,
2013
DOI:10.4252/wjsc.v5.i4.149
|
|
|
|
|
[8]
|
Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity
Clinical and Developmental Immunology,
2012
DOI:10.1155/2012/708036
|
|
|
|
|
[9]
|
Establishment of human ovarian serous carcinomas cell lines in serum free media
Methods,
2012
DOI:10.1016/j.ymeth.2012.03.003
|
|
|
|